Global private equity and venture capital news and research

Posts Tagged ‘Third Rock Ventures’

16 April 2014

Biopharma developer PanOptica scores $45m Series B investment

Biopharmaceutical company PanOptica has raised up to $45m in a Series B financing, co-led by new participant Novo Ventures and existing investor Third Rock Ventures, alongside founding investor SV Life Sciences.

20 March 2014

Third Rock, Prospect Ventures return for $34m NinePoint Medical Series B

surgey-operation-medical-healthcare-doctor-patient-hospital NinePoint Medical founding investors Third Rock Ventures and Prospect Venture Partners have renewed their commitment to the company by backing a $34m financing round.

13 March 2014

OrbiMed helps Sage Therapeutics raise $38m

medical monitor Healthcare-focused investment firm OrbiMed Advisors participated in a $38m Series C round for biopharmaceutical company Sage Therapeutics.

7 February 2014

Eleven Biotherapeutics raises $50m via IPO

dollar envelope money Venture capital-backed biopharmaceutical company Eleven Biotherapeutics has raised $50m via an IPO on the Nasdaq exchange.

25 November 2013

Flagship, Polaris, Third Rock lead $43m Series A for Editas Medicine

biotech_lrg Flagship Ventures, Polaris Partners and Third Rock Ventures have led a $43m Series A for genome editing specialist Editas Medicine.

16 October 2013

SAGE Therapeutics raises $20m from Arch Venture Partners, Third Rock

pharmaceutical 12_sq Arch Venture Partners and Third Rock Ventures have invested $20m in SAGE Therapeutics, bringing the biopharmaceutical company’s fundraising total to $57.8m.

30 July 2013

New Enterprise Associates leads $16m Series B for Edimer Pharmaceuticals

Venture capital firm New Enterprise Associates has led an $18m Series B round fro biotechnology startup Edimer Pharmaceuticals.

22 July 2013

Venture trio re-invest in medical nutrion business Alcresta through $10m round

Life Technologies Bessemer Venture Partners, Frazier Healthcare and Third Rock Ventures have re-upped their investment in medical nutrition company Alcresta by leading a $10m financing round.

11 June 2013

Third Rock, Flagship-backed Agios files for $86m Nasdaq IPOp

dna Venture capital-backed Agios Pharmaceuticals has filed to raise $86m through an IPO five years after picking up its first tranche of early-stage funding.

8 April 2013

US venture capital fundraising slows down in Q1 as exit market weakensp

The impact of the tough exit market on fundraising activity by venture capital funds was highlighted in the latest research by the NVCA.

Page 1 of 212

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014